Latest Research in Proteopathic Neurodegeneration Dynamics

Top Research Topics in Proteopathic Neurodegeneration Dynamics

• Alzheimer's disease research and treatments — 14 papers
• Parkinson's Disease Mechanisms and Treatments — 11 papers
• Neuroinflammation and Neurodegeneration Mechanisms — 6 papers
• Neuroscience and Neuropharmacology Research — 6 papers
• Anesthesia and Neurotoxicity Research — 5 papers
• Pain Mechanisms and Treatments — 5 papers
• Prion Diseases and Protein Misfolding — 5 papers
• Tryptophan and brain disorders — 3 papers
• Pharmacological Receptor Mechanisms and Effects — 3 papers
• Bipolar Disorder and Treatment — 2 papers

Highest-Cited Papers

1. Psilocybin as a treatment for repetitive mild head injury: evidence from neuroradiology and molecular biology (3 citations)
2. Behavioral outcomes after sevoflurane-based general anesthesia in preschool children: a prospective cohort study with perioperative hydrogen sulfide–related biomarker profiling
3. Targeting glial PD-1/PD-L1 restores microglial homeostasis and reduces neuronal hyperactivity in an Alzheimer’s disease model
4. Voltage-gated sodium channel, Nav 1.8, regulates calcium dynamics in the dorsal root ganglion induced by cold nociceptive stimulus
5. A simulation of recreational and addictive methamphetamine use on the integrity of the blood-brain barrier endothelium using an in vitro BBB model
6. Is adverse outcome in PrP-suppression studies attributable to the loss of PrP itself, or to the mechanism used to achieve that loss?
7. Evidence for multiple prion conformers in natural scrapie isolates
8. Astrocytic Resource Diffusion Stabilizes Persistent Activity in Neural Fields
9. Targeted degradation of RAGE restores microglial homeostasis and rescues cognitive deficits in 3xTg-AD mice
10. Lithium deficiency in Alzheimer’s disease: from cerebral bioenergetic failure to therapeutic intervention
11. Exosomal miR-223-3p, associated with NLRP3-related neuroinflammation, as a potential biomarker for mild cognitive impairment in patients with type 2 diabetes mellitus
12. Hippocampal 5-HT4/6 Receptor Antagonists Normalize Dopaminergic Dysfunction in a Rodent Model of Alzheimer’s Disease
13. Small-Molecule NANT Therapeutics Targeting the Brain–Immune Axis in Alzheimer’s Disease: Mechanisms, Clinical Progress, and Translational Challenges
14. Age-dependent changes in lipid droplet distribution and vascularization in naked mole rat vs. mouse hippocampus
15. Deep Learning‐Powered Plasmonic Platform for Decoding Dynamic Protein Aggregation Landscapes in Parkinson's Disease Progression
16. L-serine-enriched diet restores impaired adult neurogenesis in the hippocampus of 3xTg-AD mice
17. Temporal Trajectories of the Tau Aggregate Interactome Reveal Stage‐Specific Vulnerabilities in Alzheimer's Disease
18. Unconventional animal models of Alzheimer’s disease and aging: key insights from the UAMAA 2026 conference
19. THE RELATIONSHIP BETWEEN SCHIZOPHRENIA AND ALZHEIMER'S DISEASE - AN ATTEMPT TO A HOLISTIC VIEW OF NEURODEGENERATIVE DISORDERS
20. A Novel Regulatory System in Brain Development and Death Driven by a Bioactive Peptide Linked to a Specific Isoform of Acetylcholinesterase

Sub-Regions

• Parkinson's Disease Mechanisms and Treatments — 78 papers
• Prion Diseases and Protein Misfolding — 24 papers
• Alzheimer's disease research and treatments — 15 papers
• Neuroinflammation and Neurodegeneration Mechanisms — 8 papers
• Cerebrospinal fluid and hydrocephalus — 7 papers
• Amyotrophic Lateral Sclerosis Research — 5 papers